Abstract
Immune decline with ageing accounts for the increased risk of infections, inflammatory chronic disease, autoimmunity and cancer in humans. Both innate and adaptive immune functions are compromised in aged people and, therefore, attempts to correct these dysfunctions represent a major goal of modern medicine. In this review, special emphasis will be placed on the aged innate immunity with special reference to polymorphonuclear cell, monocyte/ macrophage, dendritic cell and natural killer cell functions. As potential modifiers of the impaired innate immunity, some principal nutraceuticals will be illustrated, such as micronutrients, pre-probiotics and polyphenols. In elderly, clinical trials with the above products are scanty, however, some encouraging effects on the recovery of innate immune cells have been reported. In addition, our own results obtained with symbiotics and polyphenols extracted from red wine or fermented grape marc suggest the potential ability of these substances to modulate the innate immune response in ageing, thus reducing the inflammaging which characterizes immune senescence.
Keywords: Ageing, innate immunity, prebiotics, probiotics, polyphenols.
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Disorders of Innate Immunity in Human ageing and effects of Nutraceutical Administration
Volume: 14 Issue: 4
Author(s): Thea Magrone and Emilio Jirillo
Affiliation:
Keywords: Ageing, innate immunity, prebiotics, probiotics, polyphenols.
Abstract: Immune decline with ageing accounts for the increased risk of infections, inflammatory chronic disease, autoimmunity and cancer in humans. Both innate and adaptive immune functions are compromised in aged people and, therefore, attempts to correct these dysfunctions represent a major goal of modern medicine. In this review, special emphasis will be placed on the aged innate immunity with special reference to polymorphonuclear cell, monocyte/ macrophage, dendritic cell and natural killer cell functions. As potential modifiers of the impaired innate immunity, some principal nutraceuticals will be illustrated, such as micronutrients, pre-probiotics and polyphenols. In elderly, clinical trials with the above products are scanty, however, some encouraging effects on the recovery of innate immune cells have been reported. In addition, our own results obtained with symbiotics and polyphenols extracted from red wine or fermented grape marc suggest the potential ability of these substances to modulate the innate immune response in ageing, thus reducing the inflammaging which characterizes immune senescence.
Export Options
About this article
Cite this article as:
Magrone Thea and Jirillo Emilio, Disorders of Innate Immunity in Human ageing and effects of Nutraceutical Administration, Endocrine, Metabolic & Immune Disorders - Drug Targets 2014; 14 (4) . https://dx.doi.org/10.2174/1871530314666141010105540
DOI https://dx.doi.org/10.2174/1871530314666141010105540 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Autoimmune Pancreatitis and Diagnostic Criteria
Current Immunology Reviews (Discontinued) Nimodipine Loaded PLGA Nanoparticles: Formulation Optimization Using Factorial Design,Characterization and In Vitro Evaluation
Current Drug Delivery Trends in Nanotechnology Patents Applied to the Health Sector
Recent Patents on Nanotechnology Craniofacial Fibrous Dysplasia Involvements of Mccune-Albright Syndrome: A Review with an Additional Case
Current Medical Imaging Role of Resistin in Insulin Sensitivity in Rodents and Humans
Current Protein & Peptide Science Cystatin C in Cerebrovascular Disorders
Current Neurovascular Research Meet Our Co-Editor
Cardiovascular & Hematological Agents in Medicinal Chemistry Recent Advancement in the Treatment of Cardiovascular Diseases: Conventional Therapy to Nanotechnology
Current Pharmaceutical Design Virus Vasculopathy and Stroke: An Under-Recognized Cause and Treatment Target
Infectious Disorders - Drug Targets Contrast-induced Nephropathy in Non-cardiac Vascular Procedures, A Narrative Review: Part 2
Current Vascular Pharmacology How Should Serum Uric Acid Concentrations be Interpreted in Patients with Hypertension?
Current Hypertension Reviews Review: Technegas - 99mTc-Metal Core Graphite Nanoparticles for Pulmonary Ventilation Imaging
Current Radiopharmaceuticals Diabetes, Incretin Therapy and Thoracic Aortic Aneurysm – What Does the Evidence Show?
Current Vascular Pharmacology New Perspectives on Acetaminophen
Current Cardiology Reviews Emerging Therapies for Diabetic Neuropathy: A Clinical Overview
Current Diabetes Reviews Craniofacial Anomalies: From Development to Molecular Pathogenesis
Current Molecular Medicine Protein Kinases and their Modulation in the Central Nervous System
Current Medicinal Chemistry - Central Nervous System Agents RAAS Inhibition and Cardiorenal Syndrome
Current Hypertension Reviews Risk-Benefit Perspectives in COX-2 Blockade
Current Drug Safety Peripheral Arterial Disease: The Magnitude of the Problem and its Socioeconomic Impact
Current Drug Targets - Cardiovascular & Hematological Disorders